Regulations.gov document
Virtual Public Meeting on Patient-Focused Drug Development for Systemic Sclerosis
Other · FDA-2020-N-1934 · posted Sep 18, 2020
Key facts
| Document ID | FDA-2020-N-1934-0001 |
|---|---|
| Title | Virtual Public Meeting on Patient-Focused Drug Development for Systemic Sclerosis |
| Document type | Other |
| Subtype | Additional Information |
| Agency | FDA |
| Docket | FDA-2020-N-1934 |
| Posted | Sep 18, 2020 |
| Comment period opens | Sep 18, 2020 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: